Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reation

Details for Australian Patent Application No. 2003215474 (hide)

Owner Institut de Cardiologie de Montreal / Montreal Heart Institute

Inventors Tanguay, Jean-Francois; Juneau, Martin; Brouillette, Denis

Agent Cullen & Co

Pub. Number AU-B-2003215474

PCT Number PCT/CA03/00456

PCT Pub. Number WO2003/082296

Priority 2,379,211 28.03.02 CA

Filing date 28 March 2003

Wipo publication date 13 October 2003

Acceptance publication date 20 October 2005

International Classifications

A61K 031/5415 - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61P 039/02 General protective or antinoxious agents

A61P 009/02 Drugs for disorders of the cardiovascular system

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 2,379,211 28.03.02 CA

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003215474

20 October 2005 Application Accepted

  Published as AU-B-2003215474

16 February 2006 Standard Patent Sealed

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215475-REVERSE-ORDER GAME PLAY APPARATUS

2003215473-FUEL CELL HEALTH MANAGEMENT SYSTEM